Exam (elaborations)
Karch's Focus on Nursing Pharmacology, 9th Edition by Rebecca Tucker
- Course
- Institution
- Book
Karch's Focus on Nursing Pharmacology, 9th Edition by Rebecca Tucker
[Show more]
Connected book
Book Title:
Author(s):
- Edition:
- ISBN:
- Edition:
More summaries for
-
Karch's Focus on Nursing Pharmacology, 9th Edition by Rebecca Tucker
-
Karch's Focus on Nursing Pharmacology, 9th Edition by Rebecca Tucker
-
TEST BANK For Karch Focus on Nursing Pharmacology, 9th Edition by Rebecca Tucker, Verified Chapters 1 - 59, Complete Newest Version.
Seller
Follow
kushboopatel6867
Content preview
TEST BANK For Karch's Focus on Nursing Pharmacology,9th Edition by Rebecca Tucker
acquired immunodeficiency syndrome (AIDS) - ANSWER:collection of opportunistic
infections and cancers that occurs when the immune system is severely depressed
by a decrease in the number of functioning helper T cells; caused by infection with
human immunodeficiency virus (HIV)
AIDS-related complex (ARC) - ANSWER:collection of less serious opportunistic
infections with HIV infection; the decrease in the number of helper T cells is less
severe than in fully developed AIDS
CCR5 coreceptor antagonist - ANSWER:a drug that blocks the receptor site the HIV
virus needs to interact with in order to enter the cell
cytomegalovirus (CMV) - ANSWER:DNA virus that accounts for many respiratory,
ophthalmic, and liver infections
fusion inhibitor - ANSWER:a drug that prevents the fusion of the HIV-1 virus with the
human cellular membrane, preventing it from entering the cell
helper T cell - ANSWER:human lymphocyte that helps to initiate immune reactions in
response to tissue invasion
hepatitis B - ANSWER:a serious to potentially fatal viral infection of the liver,
transmitted by body fluids
herpes - ANSWER:DNA virus that accounts for many diseases, including shingles, cold
sores, genital herpes, and encephalitis
human immunodeficiency virus (HIV) - ANSWER:retrovirus that attacks helper T cells,
leading to a decrease in immune function and AIDS or ARC
influenza A - ANSWER:RNA virus that invades tissues of the respiratory tract, causing
the signs and symptoms of the common cold or " flu"
integrase inhibitor - ANSWER:a drug that inhibits the activity of the virus-specific
enzyme integrase, an encoded enzyme needed for viral replication; blocking this
enzyme prevents the formation of the HIV-1 provirus
interferon - ANSWER:tissue hormone that is released in response to viral invasion;
blocks viral replication
nonnucleoside reverse transcriptase inhibitors - ANSWER:drugs that bind to sites on
the reverse transcriptase, preventing RNA- and DNA-dependent DNA polymerase
, activities needed to carry out the viral DNA synthesis; prevents the transfer of
information that allows the virus to replicate and survive
nucleoside reverse transcriptase inhibitors - ANSWER:drugs that prevent the growth
of the viral DNA chain, preventing it from inserting into the host DNA, so viral
replication cannot occur
protease inhibitors - ANSWER:drugs that block the activity of the enzyme protease in
HIV; protease is essential for the maturation of infectious virus, and its absence leads
to the formation of an immature and noninfective HIV particle
virus - ANSWER:particle of DNA or RNA surrounded by a protein coat that survives by
invading a cell to alter its functioning
Prototype of Agents for Influenza A and Respiratory Viruses - ANSWER:Rimantadine
Indications of Rimantadine
(Prototype of Agents for Influenza A and Respiratory Viruses) - ANSWER:Prophylaxis
and treatment of illness caused by influenza A virus in adults; prophylaxis against
influenza A virus in children.
Actions of Rimantadine
(Prototype of Agents for Influenza A and Respiratory Viruses) - ANSWER:Inhibits viral
replication, possibly by preventing the uncoating of the virus.
Adverse Effects of Rimantadine
(Prototype of Agents for Influenza A and Respiratory Viruses) - ANSWER:Affects
dopamine levels in the brain --
Light-headedness, dizziness, insomnia, nausea, dyspnea, orthostatic hypotension,
depression.
Protoype of Agents for Herpes Virus and Cytomegalovirus - ANSWER:Acyclovir
Indications of Acyclovir
(Protoype of Agents for Herpes Virus DOES NOT TREAT Cytomegalovirus) -
ANSWER:Treatment of herpes simplex virus (HSV) 1 and 2 infections; treatment of
severe genital HSV infections; treatment of HSV encephalitis; acute treatment of
shingles (herpes zoster) and chickenpox; ointment for the treatment of genital
herpes infections; cream for the treatment of cold sores (herpes labialis).
Actions of Acyclovir
(Protoype of Agents for Herpes Virus and DOES NOT TREAT Cytomegalovirus) -
ANSWER:Inhibits viral DNA replication by competing with viral substrates to form
shorter, non-effective DNA chains
Adverse Effects of Acyclovir
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller kushboopatel6867. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $17.99. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
72841 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy study notes for 14 years now